CCA
IDXX icon

Childress Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Childress Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Sell
3,279
-2,339
-42% -$1.31M 0.28% 59
2026
Q1 		$3.16M Sell
5,618
-28
-0.5% -$18K 0.57% 33
2025
Q4 		$3.82M Buy
5,646
+3
+0.1% +$2.04K 0.61% 35
2025
Q3 		$3.61M Buy
5,643
+22
+0.4% +$13.4K 0.66% 34
2025
Q2 		$3.01M Sell
5,621
-50
-0.9% -$23.9K 0.76% 30
2025
Q1 		$2.38M Buy
5,671
+17
+0.3% +$7.38K 0.69% 28
2024
Q4 		$2.34M Sell
5,654
-126
-2% -$55.3K 0.65% 30
2024
Q3 		$2.92M Buy
5,780
+3
+0.1% +$1.46K 0.79% 26
2024
Q2 		$2.81M Buy
5,777
+12
+0.2% +$6.02K 0.79% 25
2024
Q1 		$3.11M Sell
5,765
-52
-0.9% -$28.4K 0.9% 26
2023
Q4 		$3.23M Buy
5,817
+15
+0.3% +$7.04K 0.96% 23
2023
Q3 		$2.53M Buy
5,802
+602
+12% +$300K 0.83% 26
2023
Q2 		$2.61M Hold
5,200
– – 1.11% 17
2023
Q1 		$2.6M Sell
5,200
-549
-10% -$263K 1.14% 16
2022
Q4 		$2.35M Buy
5,749
+124
+2% +$48.1K 0.78% 20
2022
Q3 		$1.83M Buy
5,625
+85
+2% +$31.2K 0.71% 28
2022
Q2 		$1.94M Buy
5,540
+57
+1% +$23.2K 0.77% 23
2022
Q1 		$3M Buy
5,483
+32
+0.6% +$16.8K 1.05% 15
2021
Q4 		$3.59M Sell
5,451
-50
-0.9% -$31.4K 1.48% 14
2021
Q3 		$3.42M Buy
5,501
+7
+0.1% +$4.7K 1.39% 15
2021
Q2 		$3.47M Sell
5,494
-1
-0% -$552 1.58% 13
2021
Q1 		$2.69M Buy
5,495
+97
+2% +$48.6K 1.23% 18
2020
Q4 		$2.7M Buy
+5,398
New +$2.42M 1.58% 11

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Childress Capital Advisors's IDXX Position: Q2 2026 in Review

Childress Capital Advisors reduced its Idexx Laboratories (IDXX) stake by 42% in Q2 2026, selling an estimated $1.31M and leaving 3,279 shares worth $1.73M. The position accounts for 0.28% of the portfolio, ranked #59.

Childress Capital Advisors first reported a position in IDXX in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.82M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Childress Capital Advisors held 3,279 shares of Idexx Laboratories worth $1.73M as of Q2 2026.
  • Childress Capital Advisors sold 2,339 Idexx Laboratories shares in Q2 2026, an estimated $1.31M.
  • Idexx Laboratories made up 0.28% of Childress Capital Advisors's portfolio in Q2 2026, its #59 holding.
  • Childress Capital Advisors first reported a position in Idexx Laboratories in Q4 2020 and has held it in 23 quarters since.
  • Childress Capital Advisors's Idexx Laboratories position peaked at $3.82M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.